A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Condition:   Schizophrenia Interventions:   Drug: Brexpiprazole LAI: Dose 1;   Drug: Brexpiprazole LAI: Dose 2;   Drug: Brexpiprazole LAI: Dose 3;   Drug: Brexpiprazole LAI: Dose 4 Sponsor:   Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials